Prevalence of Viral Hepatitis in Pregnant Women in the Republic of Sakha (Yakutia)

Snezhana S. Sleptsova, PhD, ScD¹; Natalia I. Douglas, PhD, ScD¹; Yana G. Rad, PhD¹; Tatyana E. Burtseva, PhD, ScD¹,²*; Nikolai M. Gogolev, PhD¹; Diana A. Makaeva, PhD³

¹M. K. Ammosov North-Eastern Federal University, Yakutsk; ²Yakut Science Center of Complex Medical Problems, Yakutsk; ³Moscow Regional Perinatal Center, Moscow; the Russian Federation

*Corresponding author: Tatiana E. Burtseva, PhD, ScD. Yakut Science Center of Complex Medical Problems, Yakutsk, the Russian Federation. E-mail: bourtsevat@yandex.ru

Published: September 16, 2017.  doi: 10.21103/Article7(3)_OA15

Abstract: 

The prevalence of viral hepatitis in pregnant women in the Republic of Sakha (Yakutia) (RS(Y)) for 2007-2016 is presented in this article.

Keywords: 
chronic hepatitis B ● chronic hepatitis C ● mother-to-child transmission ● vaccination
References: 

1. Sleptsova SS. Viral hepatitis in the Sakha Republic (Yakutia) and their role in the development of primary liver cancer. Abstract of ScD Thesis. SPb; 2013. [in Russian].
2. Sleptsova SS, Rakhmanova AG, Douglas NI. The issues of prevention of vertical transmission of hepatitis B in the Republic of Sakha (Yakutia). In Rakhmanova AG, Yakovlev AA, editors. Almanac "Infectious diseases-2015". St Petersburg: Izd-vo FKh SPbGU; 2015:238-242.
3. Shek LA, Sleptsova SS, Douglas NI. Strategy of vaccine prophylaxis for HB infection in conditions of epidemiological trouble in the Republic of Sakha (Yakutia). Collection of scientific works of the VI Congress with international participation “Ecology and human health in the North.” Yakutsk, North-Eastern Federal University named after M.K. Ammosov, November 12-14, 2015:.[in Russian].
4. WHO. Hepatitis B. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/ Accessed June 22, 2014.
5. Rakhmanova AG, Yakovlev AA. Chronic viral hepatitis and HIV infection SPb.: "VVM"; 2011.[in Russian].
6. Wong S, Chan LY, Yu V, Ho L. Hepatitis В carrier and perinatal outcome in singleton pregnancy. Am J Perinatol.1999;16(9):485-8.
7. Wiseman E, Fraser MA, Holden S, Glass A, Kidson BL, Heron LG, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust. 2009;190(9):489-92.
8. Yogeswaran K, Fung SK. Chronic hepatitis B in pregnancy: unique challenges and opportunities. Korean J Hepatol. 2011;17(1):1–8. doi: 10.3350/kjhep.2011.17.1.1.
9. Stevens CE, Toy PT, Tong MJ, Taylor PE, Vyas GN, Nair PV, et al. Perinatal hepatitis B virus transmission in the United States: prevention by passive–active immunization. JAMA.1985;253(12):1740–5.
10. Nelson NP, Jamieson DJ, Murphy TV. Prevention of Perinatal Hepatitis B Virus Transmission. J Pediatric Infect Dis Soc. 2014; 3 Suppl 1: S7–S12. doi: 10.1093/jpids/piu064
11. Sleptsova S, Duglas NI, Shek L. Сlinical case of conducting pregnancy and childbirth at the woman with chronic viral hepatitis В in the replicative form. Wiad Lek. 2015;68(4):591-5.
12. Poland GA. Evaluating existing recommendations for hepatitis A and B vaccination. Am J Med. 2005; 118 Suppl 10A:16S-20S.
13. Global Hepatitis Report, World Health Organization, Geneva, 2017. Available from: http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?..., accessed May 2017.
14. Pan CQ, Zou HB, Chen Y, Zhang X, Zhang H, Li J, Duan Z.Clin Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants. Gastroenterol Hepatol. 2013;11(10):1349-55. doi: 10.1016/j.cgh.2013.04.026.
15. Franco E, Bagnato B, Marino MG, Meleleo C, Serino L, Zaratti L. Hepatitis B: Epidemiology and prevention in developing countries. World J Hepatol. 2012;4(3):74-80. doi: 10.4254/wjh.v4.i3.74.
16. World Health Organization. Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations. Vaccine. 2017 Jul 22. pii: S0264-410X (17) 30954-4. doi: 10.1016 / j.vaccine.2017.07.046.

The fully formatted PDF version is available.
Download Article
International Journal of Biomedicine. 2017;7(3):236-239. ©2017 International Medical Research and Development Corporation. All rights reserved